
Fernando Luis Esteban Florez DDS, PhD
Dr. Florez has significant research experience in the areas of biophotonics, development of medical devices for surface sterilization using UV-C LEDs, antimicrobial photodynamic therapy, metaloxide nanoparticles, nanostructured dental adhesive resins with antibacterial and bioactive properties, advanced microscopy techniques (SEM, TEM, Dual-FIB SEM, EDS), high-throughput bioluminescence assays. His Ph.D. dissertation focused on the antibacterial properties of novel photosensitizers such as Curcumin and Hypericin against Streptococcus mutans (planktonic and biofilms). The long-term goal of his research is the development of antibacterial and bioactive biomaterials to improve the service lives of restorative materials and dental implants.
Dr. Florez has worked as the principal investigator for six grants at local [OU Stipend Award ($20,000) and OU Growth Fund ($75,000)], state [OSCTR Pilot Grant ($75,000), OCAST HRP ($135,000)], national (Oak Ridge National Laboratory User Proposal) and international [ FAPESP, PIPE Program, phases I and II, ($537,000)] levels.
Since becoming an assistant professor at the Division of Dental Biomaterials at the College of Dentistry, he's filled a non-provisional international patent of a novel dental adhesive resin with antibacterial properties, published fourteen peer-reviewed manuscripts, presented research at national (AADR) and international conferences (IADR) and given six invited international presentations (as featured or keynote speaker) to showcase the results from those projects.
Courtney Houchen, MD
George Lynn Cross Research Professor, Department of Internal Medicine, College of Medicine
Regents’ Professor of Medicine
Eason Chair of Oncology
Chief, Digestive Diseases and Nutrition
US Patent 12,084,514 Anti-DCLK1 Antibodies and Chimeric Antigen Receptors, and Compositions and Methods of Use Thereof
CN Patent 7409669 Anti-DCLK1 Antibodies and Chimeric Antigen Receptors, and Compositions and Methods of Use Thereof
EP Patent 3630046 Anti-Doublecortin-Like Kinase 1 Antibodies and Methods of Use
Issued as Unitary Patent and in United Kingdom and Switzerland

H. Anne Pereira, PhD
Dean, Graduate College
David L. Boren Professor, Department of Pharmaceutical Sciences, College of Pharmacy
JP Patent 7606209 Peptide Therapeutics for Treating Alzheimer’s Disease and Related Conditions

Anne Kasus-Jacobi, PhD
Associate Professor, Department of Pharmaceutical Sciences, College of Pharmacy
JP Patent 7606209 Peptide Therapeutics for Treating Alzheimer’s Disease and Related Conditions

Jason Lees, MD, FACS
Robert D. Gordon, Jr. Professor of Surgery, Department of Surgery, College of Medicine
Vice Chair of Academic Affairs and Residency Program Director
Interim Section Chief of Acute Care Surgery
EP Patent 3694426 Surgical Evacuation Apparatus and Method
Issued as Unitary Patent and in United Kingdom

Dongfeng Qu, PhD
Professor of Research, Department of Internal Medicine, College of Medicine
EP Patent 3630046 Anti-Doublecortin-Like Kinase 1 Antibodies and Methods of Use
Issued as Unitary Patent and in United Kingdom and Switzerland

William Berry, PhD
Assistant Professor, Department of Surgery, College of Medicine
EP Patent 3630046 Anti-Doublecortin-Like Kinase 1 Antibodies and Methods of Use
Issued as Unitary Patent and in United Kingdom and Switzerland

Hiroshi Yamada, PhD
Assistant Professor of Research, Internal Medicine
US Patent 12,004,493 Late-Onset Alzheimer’s Disease Animal Model and Uses Thereof

Chinthalapally Rao, PhD
Professor, Department of Internal Medicine, College of Medicine
US Patent 12,004,493 Late-Onset Alzheimer’s Disease Animal Model and Uses Thereof

Venkateswararao Eeda
Assistant Professor of Research, Pharmaceutical Sciences
US Patent 11,999,677 Benzylamino-oxoethyl Benzamide Analogs and Methods of Use

Christian A. El Amm, MD
Professor, Surgery
Chief, Pediatric Plastic Surgery
US Patent 12,053,333 Surgical Enhanced Visualization System and Method of Use
US Patent 12,048,459 Distraction Osteogenesis Device and Methods

Maria Ruiz-Echevarria, PhD
Associate Professor, Department of Medicine
Section of Experimental Pathology
US Patent 12,146,139 Oligonucleotide Interference Treatments of Prostate Cancer

Rodney Tweten, PhD
George Lynn Cross Professor, Department of Microbiology and Immunology, College of Medicine
BR Patent 1120170106965 Pneumolysin Mutants and Methods of Use Thereof
EP Patent 3220937 (EP Valid) Pneumolysin Mutants and Methods of Use Thereof
